Cellular Intelligence acquires Novo Nordisk’s Parkinson’s cell therapy

Investing.com Gold reports: Cellular Intelligence acquires Novo Nordisk’s Parkinson’s cell therapy. Full body text was unavailable at ingest time, so this brief is based on headline context.